CTOs on the Move

Cascade Prosthetics and Orthotic

www.dafo.com

 
Cascade Prosthetics and Orthotic is a Ferndale, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.dafo.com
  • 1360 Sunset Ave
    Ferndale, WA USA 98248
  • Phone: 360.384.1858

Executives

Name Title Contact Details

Similar Companies

Heatmax inc

Heatmax inc is a Dalton, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Auto-rain Supply

Auto-rain Supply is a Spokane, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CareFusion

At CareFusion, we are united in our vision to improve the safety and lower the cost of healthcare for generations to come. Our 16,650 worldwide employees are passionate about healthcare and helping those that deliver it - from the hospital pharmacy to the intensive care unit, the operating theatre to the patient bedside and beyond.   Our proven product families include Intermed, AVEA, VELA, SensorMedics, AirLife and respiratory products, Pyxis automated dispensing and patient identification systems, V. Mueller and Snowden-Pencer surgical instruments, Achieve Temno and Jamshidi, and the PleurX drainage system and the Alaris IV pumps (not sold in Brazil).   To make global healthcare better, we partner with our customers to provide clinically differentiated respiratory solutions to help optimize patient care, improve medication management and lower the cost in procedural areas.

Alfa Wasserman

Alfa Wasserman is a Caldwell, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RenalGuard Solutions

Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.